Krsnaa Diagnostics Limited (KRSNAA) Price & Analysis

Compare

1 Followers

KRSNAA Stock Chart & Stats

₹735.10

₹3.75(0.41%)

At close: Jan 08 4:00 PM EST

₹735.10

₹3.75(0.41%)

Day’s Range― - ―

52-Week Range₹628.00 - ₹914.95

Previous CloseN/A

Volume110.72K

Average Volume (3M)12.28K

Market Cap

₹23.03B

Enterprise Value₹25.91B

Total Cash (Recent Filing)₹684.36M

Total Debt (Recent Filing)₹0.00

Price to Earnings (P/E)27.2

Beta1.10

Next Earnings

Feb 05, 2026

EPS Estimate

6.07

Next Dividend Ex-DateN/A

Dividend Yield0.38%

Share Statistics

EPS (TTM)7.50

Shares Outstanding32,438,670

10 Day Avg. Volume19,408

30 Day Avg. Volume12,281

Financial Highlights & Ratios

PEG Ratio0.98

Price to Book (P/B)2.95

Price to Sales (P/S)3.63

P/FCF Ratio-66.26

Enterprise Value/Market CapN/A

Enterprise Value/RevenueN/A

Enterprise Value/Gross ProfitN/A

Enterprise Value/EbitdaN/A

Forecast

1Y Price TargetN/A

Price Target UpsideN/A

Rating ConsensusN/A

Number of Analyst Covering0

EPS Forecast (FY)N/A

Revenue Forecast (FY)N/A

Bulls Say, Bears Say

Bulls Say

Strong Capital StructureA high equity ratio and very low leverage provide durable financial flexibility. Low debt reduces refinancing and interest burden risk, enabling the company to bid on capital-intensive PPP projects, fund equipment refreshes and absorb reimbursement timing shocks without stressing liquidity.

Robust Revenue & MarginsDouble-digit revenue growth paired with very high gross margins points to a scalable diagnostics model with efficient lab utilization. Durable margin strength supports reinvestment in network and technology, providing resilience to volume cycles and capacity to expand services over time.

Solid Cash ConversionOperating cash flow exceeding net income shows earnings largely convert to cash, supporting working capital and recurring equipment maintenance. Strong cash conversion underpins operational sustainability and helps fund ongoing network operations despite periodic capex needs.

Bears Say

Negative Free Cash FlowMaterial negative free cash flow driven by capital expenditure can constrain the company’s ability to self-fund expansion and equipment upgrades. Persistent FCF deficits may require external financing, increasing funding costs and exposing the business to liquidity pressure during contract or demand slowdowns.

Concentration On PPP ContractsHeavy reliance on public-private partnerships concentrates revenue exposure to tariffs, contract renewals and public payment cycles. Structural dependence creates risk of pricing pressure, slower collections and renegotiation outcomes that can materially affect volumes and margins long term.

Modest Return On EquityAn ROE below double digits suggests shareholder capital is producing moderate returns relative to growth and capital intensity. This may indicate underutilized assets or margin headroom; without efficiency or margin improvement, ROE may limit long-term shareholder value creation.

Krsnaa Diagnostics Limited News

Krsnaa Diagnostics Schedules One-on-One Investor Meet in Mumbai

Krsnaa Diagnostics Limited ( ($IN:KRSNAA) ) just unveiled an update. Krsnaa Diagnostics Limited has informed the stock exchanges...

25d ago

Krsnaa Diagnostics Schedules Investor Meeting for November 27

An update from Krsnaa Diagnostics Limited ( ($IN:KRSNAA) ) is now available. Krsnaa Diagnostics Limited has announced a...

2M ago

Krsnaa Diagnostics Releases Unaudited Financial Results for September 2025

Krsnaa Diagnostics Limited ( ($IN:KRSNAA) ) has issued an announcement. Krsnaa Diagnostics Limited announced the publication of its...

3M ago

Krsnaa Diagnostics Achieves Record Profit, Eyes Future Growth with Rajasthan Expansion

Krsnaa Diagnostics Limited ( ($IN:KRSNAA) ) has provided an update. Krsnaa Diagnostics Limited reported its highest-ever quarterly profit,...

3M ago

Krsnaa Diagnostics Schedules Investor Meeting to Enhance Stakeholder Engagement

Krsnaa Diagnostics Limited ( ($IN:KRSNAA) ) has provided an update. Krsnaa Diagnostics Limited has announced a scheduled meeting...

4M ago

Krsnaa Diagnostics Releases Q1 2025 Financial Results

The latest announcement is out from Krsnaa Diagnostics Limited ( ($IN:KRSNAA) ). Krsnaa Diagnostics Limited announced the publication...

6M ago

Krsnaa Diagnostics Releases Q1 FY2026 Financial Results

Krsnaa Diagnostics Limited ( ($IN:KRSNAA) ) just unveiled an update. Krsnaa Diagnostics Limited has released an investor presentation...

6M ago

Krsnaa Diagnostics Appoints New Managing Director Following Shareholder Approval

The latest announcement is out from Krsnaa Diagnostics Limited ( ($IN:KRSNAA) ). Krsnaa Diagnostics Limited announced the approval...

10M ago

Krsnaa Diagnostics Announces Resignation of Chief Business Officer

Krsnaa Diagnostics Limited ( ($IN:KRSNAA) ) just unveiled an update. Krsnaa Diagnostics Limited has announced the resignation of...

10M ago

Krsnaa Diagnostics Submits SEBI Compliance Certificate for Q1 2025

Krsnaa Diagnostics Limited ( ($IN:KRSNAA) ) has provided an announcement. Krsnaa Diagnostics Limited has submitted a confirmation certificate...

10M ago

KRSNAA FAQ

What was Krsnaa Diagnostics Limited’s price range in the past 12 months?

Krsnaa Diagnostics Limited lowest stock price was ₹628.00 and its highest was ₹914.95 in the past 12 months.

What is Krsnaa Diagnostics Limited’s market cap?

Krsnaa Diagnostics Limited’s market cap is ₹23.03B.

When is Krsnaa Diagnostics Limited’s upcoming earnings report date?

Krsnaa Diagnostics Limited’s upcoming earnings report date is Feb 05, 2026 which is in 4 days.

How were Krsnaa Diagnostics Limited’s earnings last quarter?

Krsnaa Diagnostics Limited released its earnings results on Nov 07, 2025. The company reported ₹7.5 earnings per share for the quarter, missing the consensus estimate of ₹7.533 by -₹0.033.

Is Krsnaa Diagnostics Limited overvalued?

According to Wall Street analysts Krsnaa Diagnostics Limited’s price is currently Overvalued. Get more investment ideas with TipRanks Premium

Does Krsnaa Diagnostics Limited pay dividends?

Krsnaa Diagnostics Limited pays a Annually dividend of ₹2.75 which represents an annual dividend yield of 0.38%. See more information on Krsnaa Diagnostics Limited dividends here

What is Krsnaa Diagnostics Limited’s EPS estimate?

Krsnaa Diagnostics Limited’s EPS estimate is 6.07.

How many shares outstanding does Krsnaa Diagnostics Limited have?

Krsnaa Diagnostics Limited has 32,438,670 shares outstanding.

What happened to Krsnaa Diagnostics Limited’s price movement after its last earnings report?

Krsnaa Diagnostics Limited reported an EPS of ₹7.5 in its last earnings report, missing expectations of ₹7.533. Following the earnings report the stock price went down -3.967%.

Which hedge fund is a major shareholder of Krsnaa Diagnostics Limited?

Currently, no hedge funds are holding shares in IN:KRSNAA

What is the TipRanks Smart Score and how is it calculated?

Smart Score combines eight research factors - such as analyst recommendations, hedge fund trends, and technical indicators - to measure a stock’s outlook. These signals are unified into a single score that reflects bullish or bearish momentum. See detailed methodology

Company Description

Krsnaa Diagnostics Limited

Krsnaa Diagnostics Limited provides diagnostic services. The company offers a range of technology-enabled diagnostic services, such as radiology, pathology/clinical laboratory, and tele-radiology services to public and private hospitals, medical colleges, and community health centers. As of December 31, 2020, it operated 1,801 diagnostic centers in 13 states across India. The company was incorporated in 2010 and is based in Pune, India.